Calambo, Rojeden P.

HRN: 29-07-95  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/04/2026
06/11/2026
SLOW IV
500mg
OD
Deep Abscess Abdominal
Checking Final Appropriateness 

Indication:  Culture-directed    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: